LANDMARK BIO
Live / Applied — Third extension granted (statement of use) (as of 01 Jan 2026)
What this means for you
Not registered yet, but its 28 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97912745
- Mark type
- Design + words
- Filed
- 28 Apr 2023
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological diseases and disorders, genetic diseases and disorders, neurodegenerative diseases and disorders, and age-related diseases and disorders
Owner
- LANDMARK BIO, PBLLC, WATERTOWN, MA, US
- LANDMARK BIO, PBLLC, WATERTOWN, MA, US
- The Center for Advanced Biological Innovation and Manufacturing, PBLLC, Watertown, MA, US
Prosecution history
- 02 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jan 2026 — SOU EXTENSION 3 GRANTED
- 30 Oct 2025 — SOU EXTENSION 3 FILED
- 30 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2025 — SOU EXTENSION 2 GRANTED
- 23 Apr 2025 — SOU EXTENSION 2 FILED
- 23 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Feb 2025 — CORRECTED NOA E-MAILED
- 05 Feb 2025 — DIVISIONAL PROCESSING COMPLETE
- 24 May 2024 — DIVISIONAL REQUEST RECEIVED
- 05 Feb 2025 — SOU EXTENSION 1 GRANTED
- 24 May 2024 — SOU EXTENSION 1 FILED
- 04 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL